Arcutis Biotherapeutics, Inc.
ARQTNasdaqCIK 1787306HealthcareFiscal year ends Dec 31
Reports and events: 133 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0516:21 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001787306-26-000051 |
| 2026-08-0516:14 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001787306-26-000049 |
| 2026-07-1616:25 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-048469 |
| 2026-06-0916:05 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-041883 |
| 2026-05-0616:06 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001787306-26-000040 |
| 2026-05-0616:03 ET | 8-K | 9.01 Financial statements and exhibits | 0001787306-26-000039 |
| 2026-04-2116:38 ET | DEF 14A | Proxy statementPeriod 2026-04-21 | 0001787306-26-000028 |
| 2026-02-2516:07 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001787306-26-000018 |
| 2026-02-2516:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001787306-26-000017 |
| 2025-12-0816:28 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001787306-25-000147 |
| 2025-10-2808:38 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001787306-25-000144 |
| 2025-10-2808:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001787306-25-000142 |
| 2025-08-2017:19 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001415889-25-022498 |
| 2025-08-0616:15 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001787306-25-000124 |
| 2025-08-0616:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001787306-25-000122 |
| 2025-06-1716:52 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001787306-25-000096 |
| 2025-05-0616:02 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001787306-25-000092 |
| 2025-05-0616:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001787306-25-000091 |
| 2025-04-2916:33 ET | DEF 14A | Proxy statementPeriod 2025-06-12 | 0001787306-25-000069 |
| 2025-04-1017:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001787306-25-000058 |
| 2025-02-2516:04 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001787306-25-000029 |
| 2025-02-2516:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001787306-25-000028 |
| 2025-01-1307:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001787306-25-000004 |
| 2024-11-0616:07 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001787306-24-000153 |
| 2024-11-0616:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001787306-24-000151 |
| 2024-08-1416:12 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001787306-24-000124 |
| 2024-08-1416:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001787306-24-000122 |
| 2024-07-2416:10 ET | 10-Q/A | Quarterly report, amendedPeriod 2024-03-31 | 0001193125-24-183778 |
| 2024-06-1816:47 ET | 8-K | 5.07 Shareholder vote results | 0001787306-24-000090 |
| 2024-05-1416:08 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001787306-24-000079 |
| 2024-05-1416:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001787306-24-000078 |
| 2024-04-2616:31 ET | DEF 14A | Proxy statementPeriod 2024-04-26 | 0001787306-24-000061 |
| 2024-04-1016:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001787306-24-000046 |
| 2024-03-0612:40 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-060422 |
| 2024-03-0416:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-008496 |
| 2024-02-2816:10 ET | 8-K | 1.01 Entry into a material agreement | 0001628280-24-007586 |
| 2024-02-2707:48 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001787306-24-000031 |
| 2024-02-2707:44 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001787306-24-000029 |
| 2024-02-1516:20 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-24-005061 |
| 2024-01-1116:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-001150 |
| 2023-12-1806:33 ET | 8-K | 8.01 Other events | 0001787306-23-000132 |
| 2023-11-0307:36 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001787306-23-000124 |
| 2023-11-0307:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001787306-23-000122 |
| 2023-10-2616:11 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-23-264081 |
| 2023-10-2316:25 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-23-034917 |
| 2023-10-1916:02 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-23-034688 |
| 2023-09-2716:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001787306-23-000109 |
| 2023-09-1516:09 ET | 10-Q/A | Quarterly report, amendedPeriod 2023-06-30 | 0001787306-23-000106 |
| 2023-09-1516:08 ET | 10-Q/A | Quarterly report, amendedPeriod 2023-03-31 | 0001787306-23-000105 |
| 2023-09-1516:07 ET | 10-K/A | Annual report, amendedPeriod 2022-12-31 | 0001787306-23-000103 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 28, 2026, 09:04 ET. Listed shows no prices and gives no investment advice.